Syros Pharmaceuticals Management
Management criteria checks 2/4
Syros Pharmaceuticals' El consejero delegado es Conley Chee , nombrado en Dec 2023, tiene un mandato de menos de un año. posee directamente 0.047% de las acciones de la empresa, con un valor de $96.11K . La antigüedad media del equipo directivo y del consejo de administración es de 1.8 años y 10.8 años, respectivamente.
Key information
Conley Chee
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 0.05% |
Management average tenure | 2yrs |
Board average tenure | 11yrs |
Recent management updates
Recent updates
Syros Pharmaceuticals: Rising Despite Dilution, A Must Look
Jan 14Syros Pharmaceuticals: A Major Vote Of Confidence From Insiders
Sep 20Syros gets FDA orphan drug designation for pancreatic cancer treatment SY-5609
Sep 13Syros Pharmaceuticals Q2 2022 Earnings Preview
Aug 08Syros Pharmaceuticals Is A Buy As New Trials Start
Nov 20Syros Pharmaceuticals (NASDAQ:SYRS) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Nov 08Syros Pharmaceuticals, Inc.'s (NASDAQ:SYRS) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 02Syros Pharma up 18% day after ARK Innovation dumps shares
May 27Analysts Just Made A Substantial Upgrade To Their Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Forecasts
May 11Does Syros Pharmaceuticals (NASDAQ:SYRS) Have A Healthy Balance Sheet?
May 07Can You Imagine How Syros Pharmaceuticals' (NASDAQ:SYRS) Shareholders Feel About The 57% Share Price Increase?
Mar 02CEO
Conley Chee (53 yo)
less than a year
Tenure
Mr. Conley Chee serves as President, Chief Executive Officer & Director at Syros Pharmaceuticals, Inc. since December 02, 203. He served as Chief Commercial Officer at Syros Pharmaceuticals, Inc. since Sep...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Scientific Founder | no data | US$239.66k | 0.15% $ 195.7k | |
Chief Medical Officer | 8.3yrs | US$1.76m | no data | |
CEO, President & Director | less than a year | no data | 0.047% $ 62.2k | |
Founder | no data | no data | no data | |
Scientific Founder & Member of Scientific Advisory Board | no data | no data | no data | |
Chief Financial Officer | 2.5yrs | US$2.82m | 0.053% $ 70.3k | |
Director of Corporate Communications & Investor Relations | no data | no data | no data | |
Chief Legal Officer & Head of Business Development | 1.5yrs | US$1.46m | 0.092% $ 122.5k | |
Vice President of Human Resources | 1.3yrs | no data | no data | |
Chief Development Officer | 3.8yrs | no data | 0.060% $ 79.6k |
2.0yrs
Average Tenure
55yo
Average Age
Equipo directivo experimentado: SYRSEl equipo directivo de la empresa se considera experimentado (2 años de antigüedad media).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Scientific Founder | 12.4yrs | US$239.66k | 0.15% $ 195.7k | |
CEO, President & Director | less than a year | no data | 0.047% $ 62.2k | |
Scientific Founder & Member of Scientific Advisory Board | 11yrs | no data | no data | |
Independent Chairman | 7.3yrs | US$211.28k | 0.045% $ 60.5k | |
Member of Scientific Advisory Board | 11yrs | no data | no data | |
Independent Director | 1.6yrs | US$135.67k | 0.045% $ 60.5k | |
Director | 11yrs | US$3.49m | 0.38% $ 504.7k | |
Member of Scientific Advisory Board | 11yrs | no data | no data | |
Member of Scientific Advisory Board | 11yrs | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | 11yrs | no data | no data | |
Member of Scientific Advisory Board | 11yrs | no data | no data |
11.0yrs
Average Tenure
62.5yo
Average Age
Junta con experiencia: SYRSLos consejos de administración de la empresa son veteranos y experimentados ( 10.7 años de permanencia media en el cargo).